Key facts
- It has raised $10.0M; the latest was Later Stage VC ($5.0M) in Aug 2025.
- Notable investors include The David and Lucile Packard Foundation.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Afaxys Pharma
- ·The full record, as it builds
Funding rounds
No funding rounds for Afaxys Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Afaxys Pharma
Developer of oral contraceptive tablets designed to provide affordable healthcare products. The company's tablets are available at family planning clinics, college and university health clinics, community health centers, and city, county and state facilities, enabling patients to have access to quality medicines thereby making reproductive and sexual health affordable.
- Sector
- Healthcare
- HQ
- Charleston, SC, United States
- Founded
- 2008
- Employees
- 43
- Website
- afaxyspharma.com/
- Ownership
- Privately Held (backing)
Afaxys Pharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Afaxys Pharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Afaxys Pharma in its N-PORT filings yet. We sweep new filings monthly.